Tsakos Energy Navigation Limited(TEN) - 2024 Q4 - Earnings Call Presentation
2025-03-27 20:49
Q4 & YE 2024 Earnings Presentation March 27, 2025 TEN, Ltd. This presentation may contain forward-looking statements that are not based on historical fact, including without limitation, statements containing the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions. Because these forward-looking statements involve known and unknown risks and uncertainties, there are important factors that could cause actual results, events or developments to differ mate ...
TD SYNNEX (SNX) - 2025 Q1 - Earnings Call Transcript
2025-03-27 20:42
Financial Data and Key Metrics Changes - Gross billings increased by 7.5% year over year in Q1, and 9.5% in constant currency, reaching $20.7 billion [7][22] - Net revenue was $14.5 billion, up 4% year over year, with a gross to net adjustment of approximately 30% [23][30] - Gross profit was $1 billion, representing 4.82% of gross billings, with a year-over-year decline of 40 basis points [24] - Non-GAAP net income was $237 million, with diluted earnings per share at $2.80, both within guidance range [27][30] Business Line Data and Key Metrics Changes - Advanced Solutions grew by 7% year over year, driven by demand for integrated IT solutions [7][23] - Endpoint solutions grew by 8% year over year, with growth across PCs and mobile [7][23] - Hive experienced double-digit growth year over year but was below expectations due to component shipment delays and demand shortfalls [8][39] Market Data and Key Metrics Changes - Latin America and APJ regions grew by double digits in Q1 in constant currency, indicating strong market performance [11][12] - The company expanded its reach to 30,000 active partners and 500,000 end users through its cloud marketplace [10] Company Strategy and Development Direction - The company focuses on profitable growth and free cash flow, with a commitment to mid-single-digit gross billings growth for fiscal 2025 [21][33] - The strategy includes enhancing digital capabilities and expanding partnerships in high-growth markets [10][16] - The company aims to adapt to the evolving IT landscape, driven by trends such as cloud, cybersecurity, and AI [12][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the normalization of business conditions despite temporary softness in Hive [9][40] - The company remains optimistic about the demand environment and its ability to grow, particularly in strategic technologies [42][78] - Management highlighted the importance of maintaining specialized resources to support future demand [61][68] Other Important Information - The company returned $138 million to stockholders in Q1, including $101 million in share repurchases and $37 million in dividends [28] - The Board of Directors approved a cash dividend of $0.44 per common share, payable on April 25, 2025 [29] Q&A Session Summary Question: Can you provide more details on Hive and the reasons for the softer demand? - Management acknowledged that Hive experienced double-digit growth but faced temporary demand pauses and shipment delays, which are expected to normalize in Q2 [39][40] Question: Did you see any pre-buying by customers to avoid tariff increases? - Management indicated that the impact of tariffs has been limited, with growth driven by PC refresh cycles rather than pre-buying [46][48] Question: What are the expectations regarding price increases from vendors? - Management noted that while some vendors are increasing prices, it is not widespread and is being monitored closely [54] Question: Can you clarify the impact of Hive on cash flow and capital allocation? - Management explained that elevated inventory and payables impacted cash flow, but they expect recovery in cash conversion days moving forward [63][67] Question: How does the company view its geographic exposure relative to competitors? - Management highlighted strong market positions in North America and Europe, with opportunities for growth in Latin America and APJ [99][100]
Oi(OIBZQ) - 2024 Q4 - Earnings Call Transcript
2025-03-27 20:32
Marcelo Milliet My name is Marcelo Milliet. I'm the CEO of Oi, and we're going to have Rodrigo Aguiar, our CFO; and some members of our Executive Board with us, as well as our Investor Relations Team. I'm going to be using this first chapter of the presentation to recap some important steps the company took in 2024, and also to clarify what the new Oi is going to be like in the future. In the second chapter, we'll go through the fourth quarters figures, and then we'll open up to your questions, I'll show yo ...
INmune Bio(INMB) - 2024 4 - Earnings Call Transcript
2025-03-27 20:30
INmune Bio Inc. (INMB) Q4 2024 Earnings Conference Call March 27, 2025 04:30 PM ET Company Participants Margo - Conference OperatorDavid Moss - Chief Financial Officer, ImmuneBioDr. RJ Tessie - CEO and Co-founder, ImmuneBioDr. CJ Barnum - Clinical Executive, ImmuneBioDr. Mark Liddell - Clinical Executive, ImmuneBioModerator - Call ModeratorCall Facilitator - Investor Relations Facilitator Conference Call Participants George Farmer - Analyst, ScotiabankTom Schrader - Analyst, BTIGDennis Resnick - Analyst (su ...
Clearside Biomedical(CLSD) - 2024 4 - Earnings Call Transcript
2025-03-27 20:30
Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call March 27, 2025 04:30 PM ET Company Participants Jenny Coben - Investor Relations HostGeorge Ledeske - Chief Executive OfficerDaniel Gatua - Questioner, ShardaCharlie Degnan - Chief Financial OfficerAndreas Argarides (via Eka) - Questioner, OppenheimerDevanjana Chatterjee - Questioner, Jones TradingDr. Victor Chong - Chief Medical Officer and Head of Research and DevelopmentMr. Leszczyk - Conference Operator/ModeratorPaul - Questioner (Affili ...
STRATA Skin Sciences(SSKN) - 2024 4 - Earnings Call Transcript
2025-03-27 20:30
Strata Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Conference Call March 27, 2025 04:30 PM ET Company Participants Dr. Dolev Raffaele - Chief Executive OfficerJohn Gillings - Vice President of FinanceOperator - Conference Call OperatorLouie Thoma - Investor Relations Representative, Core IR Conference Call Participants Jeremy Pearlman - Analyst, Maxim GroupJeffrey Cohen - Analyst, Leidenberg Thalmann Operator Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Strata Sciences, ...
Barfresh(BRFH) - 2024 4 - Earnings Call Transcript
2025-03-27 20:30
Barfresh Food Group Inc. (BRFH) Q4 2024 Earnings Conference Call March 27, 2025 04:30 PM ET Company Participants Ricardo Del Coste - CEO, Barfresh GroupLisa Rogers - CFO, Food GroupOperator - Teleconference OperatorOperator - Teleconference OperatorModerator - Conference Call Moderator Conference Call Participants Nicholas Sherwood - Analyst, Maxim Group Moderator Food Group CFO, Lisa Rogers. Following prepared remarks, we will open the call for your questions. The discussion today will include forward-look ...
lululemon(LULU) - 2024 4 - Earnings Call Transcript
2025-03-27 20:30
lululemon athletica inc. (LULU) Q4 2024 Earnings Conference Call March 27, 2025 04:30 PM ET Company Participants Jeff Walker - Vice President at the Howard GroupRandy Boomhauer - CEO and President of SimatrixMJ Kent - CFO of Simatrix Jeff Walker Looks like everyone's coming in. So first, thank you everybody for joining us today. I'm Jeff Walker, Vice President at the Howard Group. We're speaking with Randy Boomhauer, CEO and President, and MJ Kent, who is CFO of Simatrix. We'll go through the presentation d ...
Pulse Biosciences(PLSE) - 2024 4 - Earnings Call Transcript
2025-03-27 20:30
Pulse Biosciences, Inc (PLSE) Q4 2024 Earnings Conference Call March 27, 2025 04:30 PM ET Company Participants Luella - Conference OperatorNot Provided - Conference Call Moderator (Operator Instructions)Tripp Taylor - Investor RelationsNot Provided - Legal/Compliance Disclaimer RepresentativePaul LaViolette - Co‐Chair of the Board and Chief Executive OfficerJohn Skinner - Chief Financial OfficerPaula Violet - Closing Remarks Luella Thank you for standing by. My name is Luella, and I will be your conference ...
Lantern Pharma(LTRN) - 2024 Q4 - Earnings Call Presentation
2025-03-27 20:25
Corporate Overview March 2025 NASDAQ: LTRN Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among other things, statements relating to: future events or our future financial performance; the potential advantages of our RADR® platform in identifying drug candidates and patient populations that ...